Hepion Pharmaceuticals, Inc.
HEPA
$0.0642
-$0.0014-2.13%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 919.50K | 1.26M | 1.79M | 1.70M | 1.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.34M | 1.28M | 1.20M | 4.46M | 8.50M |
| Operating Income | -1.34M | -1.28M | -1.20M | -4.46M | -8.50M |
| Income Before Tax | -1.04M | -6.11M | -1.55M | -4.87M | -3.93M |
| Income Tax Expenses | -- | -- | 0.00 | -- | -- |
| Earnings from Continuing Operations | -1.04M | -6.11M | -1.55M | -4.87M | -3.93M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.04M | -6.11M | -1.55M | -4.87M | -3.93M |
| EBIT | -1.34M | -1.28M | -1.20M | -4.46M | -8.50M |
| EBITDA | -1.34M | -1.27M | -1.20M | -4.46M | -8.50M |
| EPS Basic | -0.09 | -2.15 | -11.11 | -36.21 | -33.84 |
| Normalized Basic EPS | -0.07 | -0.29 | -11.75 | -22.94 | -45.56 |
| EPS Diluted | -0.09 | -2.15 | -11.11 | -36.21 | -33.84 |
| Normalized Diluted EPS | -0.07 | -0.29 | -11.75 | -22.94 | -45.56 |
| Average Basic Shares Outstanding | 11.33M | 2.84M | 139.30K | 134.40K | 116.00K |
| Average Diluted Shares Outstanding | 11.33M | 2.84M | 139.30K | 134.40K | 116.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |